{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:31:07Z","timestamp":1793741467883,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.colsurfb.2024.114121","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T16:24:12Z","timestamp":1721751852000},"page":"114121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Enhanced targeted liposomal delivery of imiquimod via aptamer functionalization for head and neck cancer therapy"],"prefix":"10.1016","volume":"243","author":[{"given":"J\u00e9ssica","family":"Lopes-Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-1242","authenticated-orcid":false,"given":"Carla","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2024.114121_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-019-0602-7","article-title":"Human papillomavirus as a driver of head and neck cancers","author":"Sabatini","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.colsurfb.2024.114121_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105177","article-title":"Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: a systematic review of population-based studies","author":"Menezes","year":"2021","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s12105-012-0377-0","article-title":"Epidemiology and clinical aspects of HPV in head and neck cancers","author":"Chaturvedi","year":"2012","journal-title":"Head. Neck Pathol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.618931","article-title":"Current trends of targeted drug delivery for oral cancer therapy","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib5","unstructured":"Drugs Approved for Head and Neck Cancer, (n.d.). \u3008https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/head-neck\u3009 (accessed July 17, 2024)."},{"key":"10.1016\/j.colsurfb.2024.114121_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101426","article-title":"Therapeutic approaches for the treatment of head and neck squamous cell carcinoma\u2013an update on clinical trials","author":"Goel","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: Adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: pros, cons and beyond","author":"Tan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2024.114121_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2022.08.058","article-title":"Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen","author":"AL Fayez","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114121_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0000000000004384","article-title":"Topical imiquimod for the treatment of high-grade squamous intraepithelial lesions of the cervix: a Randomized controlled trial","author":"Fonseca","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s00430-002-0172-8","article-title":"Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod","author":"Wenzel","year":"2003","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdcr.2017.04.008","article-title":"Topical imiquimod for the palliative treatment of recurrent oral squamous cell carcinoma","author":"Wester","year":"2017","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.colsurfb.2024.114121_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - The first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114121_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2023.08.006","article-title":"Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment","author":"Nguyen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114121_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123577","article-title":"Nanoformulations for dermal delivery of imiquimod: The race of \u201csoft\u201d against \u201chard\u201d","volume":"648","author":"Petrov\u00e1","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114121_bib16","article-title":"Targeted delivery of liposomal chemoimmunotherapy for cancer treatment","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib17","doi-asserted-by":"crossref","DOI":"10.1021\/acs.bioconjchem.1c00139","article-title":"Large, Anionic liposomes enable targeted intraperitoneal delivery of a TLR 7\/8 agonist to repolarize ovarian tumors\u2019 microenvironment","author":"Kang","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.colsurfb.2024.114121_bib18","article-title":"A physiologically responsive nanocomposite hydrogel for treatment of head and neck squamous cell carcinoma via proteolysis-targeting chimeras enhanced immunotherapy","author":"Wu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2024.114121_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jps.23386","article-title":"Development of imiquimod-loaded mucoadhesive films for oral dysplasia","author":"Ramineni","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2024.114121_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/ph14070671","article-title":"G-quadruplex-based drug delivery systems for cancer therapy","volume":"14","author":"Lopes-Nunes","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.colsurfb.2024.114121_bib21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molmed.2020.05.002","article-title":"G-quadruplex, friend or foe: the role of the G-quartet in anticancer strategies","volume":"26","author":"Carvalho","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.colsurfb.2024.114121_bib22","first-page":"1","article-title":"Nucleolin overexpression confers increased sensitivity to the anti-nucleolin aptamer, AS1411","volume":"0","author":"Sharma","year":"2018","journal-title":"Cancer Invest"},{"key":"10.1016\/j.colsurfb.2024.114121_bib23","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1039\/C9OB00318E","article-title":"Aptamer-guided acridine derivatives for cervical cancer","volume":"17","author":"Carvalho","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.colsurfb.2024.114121_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biochi.2022.05.002","article-title":"Stabilization of a DNA aptamer by ligand binding","volume":"200","author":"Santos","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.colsurfb.2024.114121_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2015.03.023","article-title":"The roles of nucleolin subcellular localization in cancer","author":"Berger","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.colsurfb.2024.114121_bib26","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1093\/nar\/gkx274","article-title":"G-quadruplex structure of an anti-proliferative DNA sequence","volume":"45","author":"Do","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.colsurfb.2024.114121_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118511","article-title":"AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells","volume":"568","author":"Figueiredo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114121_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/j.2042-7158.1991.tb06657.x","article-title":"A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes","author":"Perrett","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib29","doi-asserted-by":"crossref","first-page":"36219","DOI":"10.1039\/D0RA07325C","article-title":"Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion","volume":"10","author":"Nsairat","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2024.114121_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.129157","article-title":"RNA-based liposomes for oral cancer: from biophysical characterization to biological evaluation","author":"Lopes-Nunes","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/pharmaceutics16070864","article-title":"Imiquimod-loaded nanosystem for treatment human papillomavirus-induced lesions","volume":"16","author":"Maocha","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2024.114121_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/polym8110397","article-title":"Co-delivery of imiquimod and plasmid DNA via an amphiphilic pH-responsive star polymer that forms unimolecular micelles in water","author":"Lin","year":"2016","journal-title":"Polymers"},{"key":"10.1016\/j.colsurfb.2024.114121_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102429","article-title":"Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro","author":"Carvalho","year":"2021","journal-title":"Nanomed. Nanotechnol.\u00a0Biol. Med."},{"key":"10.1016\/j.colsurfb.2024.114121_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164038","article-title":"Aptamer-functionalized gold nanoparticles for drug delivery to gynecological carcinoma cells","author":"Lopes-Nunes","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2024.114121_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0067-7","article-title":"Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer article","author":"Wolfson","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2024.114121_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.colsurfb.2024.114121_bib37","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S398802","article-title":"Smart chondroitin sulfate micelles for effective targeted delivery of doxorubicin against breast cancer metastasis","author":"Yu","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2024.114121_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.13235","article-title":"Imiquimod in dermatology: an overview","author":"Hanna","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2023.03.006","article-title":"A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes","author":"Agallou","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114121_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103920","article-title":"Phthalocyanines for G-quadruplex aptamers binding","volume":"100","author":"Lopes-Nunes","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.colsurfb.2024.114121_bib41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbagen.2016.12.015","article-title":"G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms","volume":"1861","author":"Bates","year":"2017","journal-title":"Biochim. Biophys. Acta\u00a0Gen. Subj."},{"key":"10.1016\/j.colsurfb.2024.114121_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2024.114121_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2015.01.032","article-title":"An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance","volume":"208","author":"Liao","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2024.114121_bib44","article-title":"A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents","author":"V.V.S.N.L. Andra","year":"2022","journal-title":"Bionanoscience"},{"key":"10.1016\/j.colsurfb.2024.114121_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/nrc903","article-title":"Ligand-targeted therapeutics in anticancer therapy","author":"Allen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2024.114121_bib46","doi-asserted-by":"crossref","first-page":"22270","DOI":"10.18632\/oncotarget.4207","article-title":"AS1411-conjugated gold nanospheres and their potential for breast cancer therapy","volume":"6","author":"Malik","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2024.114121_bib47","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.0022-202X.2004.22528.x","article-title":"Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod","volume":"122","author":"Schon","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib48","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/jid.2014.194","article-title":"Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization","volume":"134","author":"Aspord","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib49","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1158\/0008-5472.CAN-10-0920","article-title":"A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism","volume":"70","author":"Reyes-Reyes","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2024.114121_bib50","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1002\/anie.200901452","article-title":"Reversible cell-specific drug delivery with aptamer-functionalized liposomes","volume":"48","author":"Cao","year":"2009","journal-title":"Angew. Chem.\u00a0Int. Ed."},{"key":"10.1016\/j.colsurfb.2024.114121_bib51","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1039\/C8TB01563E","article-title":"AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies","volume":"6","author":"Riccardi","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2024.114121_bib52","article-title":"In vivo and in vitro anticancer activity of doxorubicin-loaded DNA-auNP nanocarrier for the ovarian cancer treatment","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2024.114121_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0714.2012.01158.x","article-title":"Toll-like receptor 7 agonist, Imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis","author":"Ahn","year":"2012","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.colsurfb.2024.114121_bib54","doi-asserted-by":"crossref","DOI":"10.1159\/000504651","article-title":"Unique patterns of distant metastases in HPV-positive head and neck cancer","author":"Sacks","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.colsurfb.2024.114121_bib55","doi-asserted-by":"crossref","DOI":"10.1159\/000454696","article-title":"Underlying mechanisms for distant metastasis - molecular biology","author":"Pachmayr","year":"2017","journal-title":"Visc. Med."},{"key":"10.1016\/j.colsurfb.2024.114121_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100899","article-title":"Plasticity of cancer cell invasion: patterns and mechanisms","author":"Wu","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2015.03.008","article-title":"Tissue invasion and metastasis: molecular, biological and clinical perspectives","author":"Jiang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043763","article-title":"Use of 3D spheroid models for the assessment of RT response in head and neck cancer","author":"Wegge","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2024.114121_bib59","doi-asserted-by":"crossref","unstructured":"V.F. Mestre, B. Medeiros-Fonseca, D. Est\u00eav\u00e3o, et al., HPV16 is sufficient to induce squamous cell carcinoma specifically in the tongue base in transgenic mice, J. Pathol. (n.d.). \u3008https:\/\/doi.org\/10.1002\/path.5387\u3009.","DOI":"10.1002\/path.5387"},{"key":"10.1016\/j.colsurfb.2024.114121_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00416","article-title":"Nanoparticle interactions with the immune system: clinical implications for liposome-based cancer chemotherapy","author":"La-Beck","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00220","article-title":"Harnessing liposome interactions with the immune system for the next breakthrough in cancer drug delivery","author":"La-Beck","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2024.114121_bib62","article-title":"Smart intraoral systems for advanced drug delivery","author":"Liu","year":"2022","journal-title":"MedComm\u00a0Biomater. Appl."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776524003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T17:14:25Z","timestamp":1732468465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776524003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":62,"alternative-id":["S0927776524003801"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114121","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced targeted liposomal delivery of imiquimod via aptamer functionalization for head and neck cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114121"}}